EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro

Alexandria A Oviatt iD, Jessica A Collins iD, Chelsea A Mann, Jianzhong Huang, Karen Mattern, Pan F Chan iD, Neil Osheroff iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Alexandria A Oviatt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, DNA Gyrase, DNA Topoisomerase IV, Anti-Bacterial Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeDNA GyraseDNA Topoisomerase IVAnti-Bacterial AgentsAcenaphthenesHeterocyclic Compounds, 3-RingTopoisomerase II InhibitorsHumansMicrobial Sensitivity TestsGonorrheaDrug Resistance, Bacterial

Stichwörter der Autor:innen

DNA cleavageDNA supercoiling/decatenationNeisseria gonorrhoeaegepotidacingyrasetopoisomerase IV

Substanzen

gepotidacinDNA GyraseDNA Topoisomerase IVAnti-Bacterial AgentsAcenaphthenesHeterocyclic Compounds, 3-RingTopoisomerase II Inhibitors

Autor:innen und Institutionen

  • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
  • Infectious Diseases Research, GSK, Collegeville, Pennsylvania 19426, United States.
  • Infectious Diseases Research, Vaccines Research and Development Infectious Diseases Research, GSK, Collegeville, Pennsylvania 19426, United States.
  • Departments of Biochemistry and Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.

ORCID-Profile: Alexandria A Oviatt, Jessica A Collins, Pan F Chan, Neil Osheroff

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • BLRD VA
  • NIGMS NIH HHS
  • U.S. Department of Health and Human Services
  • U.S. Department of Veterans Affairs

Zitieren

APA

Oviatt, A. A., Collins, J. A., Mann, C. A., Huang, J., Mattern, K., Chan, P. F., & Osheroff, N. (2025). Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00497

Vancouver

Oviatt AA, Collins JA, Mann CA, Huang J, Mattern K, Chan PF, et al. Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00497

BibTeX
@article{Oviatt2025,
  author = {Oviatt, Alexandria A and Collins, Jessica A and Mann, Chelsea A and Huang, Jianzhong and Mattern, Karen and Chan, Pan F and Osheroff, Neil},
  title = {Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00497}
}
Kostenlos starten →